Colgate Palmolive (CL)

Colgate Palmolive (CL) is facing a challenging year, particularly in the consumer staples sector. However, the company has recently demonstrated resilience by beating both top and bottom line expectations, suggesting a recovery in its performance. Additionally, improvements in its supply chain may further support its growth prospects. While the company is dealing with tariff costs that were originally projected at $200 million but have now reduced to $75 million, this represents a positive development. Investors are encouraged to consider buying the stock at its 52-week lows, especially with a dividend yield of approximately 2.5%, indicating potential for steady returns.